Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the effect of long-term PDE5 inhibition on glucose homeostasis in individuals with impaired glucose tolerance. The study was terminated,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PDE5 inhibitor

Snippet

Sponsor: Vanderbilt University | Conditions: Impaired Glucose Tolerance | Phase 4 | Status: TERMINATED | Results posted: 2017-04-17